×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CYTH – cyclo therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CYTH
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/14
08:22 am
cyth
Cyclo Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
High
Report
Cyclo Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
11/14
08:05 am
cyth
Cyclo Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
High
Report
Cyclo Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
9/6
08:09 pm
cyth
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ARCH, CYTH, VGR on Behalf of Shareholders
Low
Report
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ARCH, CYTH, VGR on Behalf of Shareholders
9/5
09:18 am
cyth
Cyclo Therapeutics Presents Encouraging Preliminary Safety Data from Ongoing Pivotal Phase 3 Study and Substudy for the Treatment of Niemann-Pick Disease Type C1 (NPC1) [Yahoo! Finance]
Medium
Report
Cyclo Therapeutics Presents Encouraging Preliminary Safety Data from Ongoing Pivotal Phase 3 Study and Substudy for the Treatment of Niemann-Pick Disease Type C1 (NPC1) [Yahoo! Finance]
9/5
09:05 am
cyth
Cyclo Therapeutics Presents Encouraging Preliminary Safety Data from Ongoing Pivotal Phase 3 Study and Substudy for the Treatment of Niemann-Pick Disease Type C1 (NPC1)
Medium
Report
Cyclo Therapeutics Presents Encouraging Preliminary Safety Data from Ongoing Pivotal Phase 3 Study and Substudy for the Treatment of Niemann-Pick Disease Type C1 (NPC1)
8/27
09:16 am
cyth
Cyclo Therapeutics, Inc. (NASDAQ: CYTH) had its "hold" rating re-affirmed by analysts at Maxim Group.
Medium
Report
Cyclo Therapeutics, Inc. (NASDAQ: CYTH) had its "hold" rating re-affirmed by analysts at Maxim Group.
8/26
05:41 pm
cyth
CYCLO THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Cyclo Therapeutics, Inc. - CYTH
Medium
Report
CYCLO THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Cyclo Therapeutics, Inc. - CYTH
8/26
01:50 pm
cyth
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VGR, CYTH, ARCH, CEIX on Behalf of Shareholders
Low
Report
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VGR, CYTH, ARCH, CEIX on Behalf of Shareholders
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/18
02:11 pm
cyth
Form 4 Cyclo Therapeutics, Inc. For: Nov 15 Filed by: SHANAHAN WILLIAM S
Medium
Report
Form 4 Cyclo Therapeutics, Inc. For: Nov 15 Filed by: SHANAHAN WILLIAM S
11/18
02:11 pm
cyth
Form 4 Cyclo Therapeutics, Inc. For: Nov 15 Filed by: Cross Shawn
Medium
Report
Form 4 Cyclo Therapeutics, Inc. For: Nov 15 Filed by: Cross Shawn
11/18
02:11 pm
cyth
Form 4 Cyclo Therapeutics, Inc. For: Nov 15 Filed by: CONKLING WILLIAM
Medium
Report
Form 4 Cyclo Therapeutics, Inc. For: Nov 15 Filed by: CONKLING WILLIAM
11/18
02:10 pm
cyth
Form 4 Cyclo Therapeutics, Inc. For: Nov 15 Filed by: Toig Randall M.
Medium
Report
Form 4 Cyclo Therapeutics, Inc. For: Nov 15 Filed by: Toig Randall M.
11/18
02:10 pm
cyth
Form 4 Cyclo Therapeutics, Inc. For: Nov 15 Filed by: STRATTAN CE RICK
Medium
Report
Form 4 Cyclo Therapeutics, Inc. For: Nov 15 Filed by: STRATTAN CE RICK
11/18
02:10 pm
cyth
Form 4 Cyclo Therapeutics, Inc. For: Nov 15 Filed by: Sieger Markus
Medium
Report
Form 4 Cyclo Therapeutics, Inc. For: Nov 15 Filed by: Sieger Markus
11/18
02:09 pm
cyth
Form 4 Cyclo Therapeutics, Inc. For: Nov 15 Filed by: Wong Vivien
Medium
Report
Form 4 Cyclo Therapeutics, Inc. For: Nov 15 Filed by: Wong Vivien
11/14
06:03 am
cyth
Form 10-Q Cyclo Therapeutics, Inc. For: Sep 30
High
Report
Form 10-Q Cyclo Therapeutics, Inc. For: Sep 30
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: